EASOM ERIC (Chief Executive Officer) received a stock award from AN2 THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/23/2026ACC: 0001193125-26-064151
DirectorOfficer· Chief Executive Officer
Since Mar 2022
+336.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
336.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+112.25K
Price / share
—
Trade value
—
% of position
43.8%
2/20/2026
256.38K→368.63K
Total
Net shares
+112.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2026 | A · Award | +112.25K | — | — | 43.8% | 256.38K | 368.63K |
| Total | +112.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
224.50K shares
Shares
+224.50K
Strike price
1.04
Held after
224.50K
Exercisable
—
2/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock224.50K shares | 2/20/2026 | A · Award | +224.50K | 1.04 | — | 224.50K |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned97.06K
Common Stock
IndirectShares owned1.07M
Common Stock
IndirectShares owned97.06K
Total
1.26M indirect1.26M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 97.06K | Indirect |
| Common Stock | 1.07M | Indirect |
| Common Stock | 97.06K | Indirect |
| Total | 1.26M | 1.26M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported